Search results
Results from the WOW.Com Content Network
WuXi PharmaTech was founded in December 2000 in Shanghai by organic chemist Ge Li. [1] [2]The company opened chemistry facilities in Tianjin in 2007. In 2008, WuXi PharmaTech acquired AppTec Laboratory Services Inc., a US-based company founded in 2001 with expertise in medical-device and biologics testing and with facilities in St. Paul, MN; Philadelphia, PA; and Atlanta, GA.
Code Short-name Full name Listing date Issued capital Negotiable capital Industry Http English Chinese 000100: TCL: TCL集团: TCL Corporation: 30.01.2004: 13,549,648,507
The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China (Hong Kong-listed) 25 Index in 2020.
China's Ministry of Commerce said it would impose measures on 28 U.S. entities and would also prohibit exports of dual-use items to the listed companies starting on Thursday, reported the Global ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Shares have fallen in Asia after China reported that its economy grew at a 4.9% annual pace in July-September, down from 6.3% in the previous quarter. U.S. futures also fell, while oil prices ...
The headquarters of the electric utility company State Grid in Beijing. It was China's largest and the world's third-largest company by revenue in 2021, with annual revenues of over US$460 billion. [1] The Industrial and Commercial Bank of China was both China and the world's largest company by assets in 2021, with over US$5.5 trillion in total ...
The Quality of drugs and Active Pharmaceutical Ingredients (API) made by Chinese pharmaceutical companies is often poor. In the past three years 2015–2017, there were 35 FDA warning letters to Chinese pharmaceutical companies citing serious Data Integrity issues, including data deletion or manipulation or fabrication of test results, see "An Analysis of 2017 FDA Warning Letters on Data ...